420 related articles for article (PubMed ID: 19601593)
1. Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease.
Jiang D; Li X; Williams R; Patel S; Men L; Wang Y; Zhou F
Biochemistry; 2009 Aug; 48(33):7939-47. PubMed ID: 19601593
[TBL] [Abstract][Full Text] [Related]
2. Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance.
Jiang D; Men L; Wang J; Zhang Y; Chickenyen S; Wang Y; Zhou F
Biochemistry; 2007 Aug; 46(32):9270-82. PubMed ID: 17636872
[TBL] [Abstract][Full Text] [Related]
3. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
4. Binding of alpha-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes.
Peng Y; Wang C; Xu HH; Liu YN; Zhou F
J Inorg Biochem; 2010 Apr; 104(4):365-70. PubMed ID: 20005574
[TBL] [Abstract][Full Text] [Related]
5. Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.
Jiang D; Li X; Liu L; Yagnik GB; Zhou F
J Phys Chem B; 2010 Apr; 114(14):4896-903. PubMed ID: 20302320
[TBL] [Abstract][Full Text] [Related]
6. Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT
Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262
[TBL] [Abstract][Full Text] [Related]
7. Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide β-amyloid (1-42).
Everett J; Céspedes E; Shelford LR; Exley C; Collingwood JF; Dobson J; van der Laan G; Jenkins CA; Arenholz E; Telling ND
J R Soc Interface; 2014 Jun; 11(95):20140165. PubMed ID: 24671940
[TBL] [Abstract][Full Text] [Related]
8. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
Smith DG; Cappai R; Barnham KJ
Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
[TBL] [Abstract][Full Text] [Related]
9. Amyloid beta-Cu2+ complexes in both monomeric and fibrillar forms do not generate H2O2 catalytically but quench hydroxyl radicals.
Nadal RC; Rigby SE; Viles JH
Biochemistry; 2008 Nov; 47(44):11653-64. PubMed ID: 18847222
[TBL] [Abstract][Full Text] [Related]
10. The initial stage of structural transformation of Aβ
Vahed M; Sweeney A; Shirasawa H; Vahed M
Comput Biol Chem; 2019 Dec; 83():107128. PubMed ID: 31585353
[TBL] [Abstract][Full Text] [Related]
11. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
Faller P; Hureau C; La Penna G
Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
[TBL] [Abstract][Full Text] [Related]
12. Spectral analysis of Fe(III)-complex reduction by hemoglobin: possible mechanisms of interaction.
Harrington JP; Hicks RL
Int J Biochem; 1994 Sep; 26(9):1111-7. PubMed ID: 7988735
[TBL] [Abstract][Full Text] [Related]
13. Copper and heme-mediated Abeta toxicity: redox chemistry, Abeta oxidations and anti-ROS compounds.
Chassaing S; Collin F; Dorlet P; Gout J; Hureau C; Faller P
Curr Top Med Chem; 2012; 12(22):2573-95. PubMed ID: 23339309
[TBL] [Abstract][Full Text] [Related]
14. Bacterial Pu(V) reduction in the absence and presence of Fe(III)-NTA: modeling and experimental approach.
Deo RP; Rittmann BE; Reed DT
Biodegradation; 2011 Sep; 22(5):921-9. PubMed ID: 21234648
[TBL] [Abstract][Full Text] [Related]
15. Evidence of redox-active iron formation following aggregation of ferrihydrite and the Alzheimer's disease peptide β-amyloid.
Everett J; Céspedes E; Shelford LR; Exley C; Collingwood JF; Dobson J; van der Laan G; Jenkins CA; Arenholz E; Telling ND
Inorg Chem; 2014 Mar; 53(6):2803-9. PubMed ID: 24559299
[TBL] [Abstract][Full Text] [Related]
16. Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.
Atwood CS; Perry G; Zeng H; Kato Y; Jones WD; Ling KQ; Huang X; Moir RD; Wang D; Sayre LM; Smith MA; Chen SG; Bush AI
Biochemistry; 2004 Jan; 43(2):560-8. PubMed ID: 14717612
[TBL] [Abstract][Full Text] [Related]
17. Kinetics and mechanisms of the oxidation of myoglobin by Fe(III) and Cu(II) complexes.
Hegetschweiler K; Saltman P; Dalvit C; Wright PE
Biochim Biophys Acta; 1987 Apr; 912(3):384-97. PubMed ID: 3567208
[TBL] [Abstract][Full Text] [Related]
18. Copper(II) binding to amyloid-beta fibrils of Alzheimer's disease reveals a picomolar affinity: stoichiometry and coordination geometry are independent of Abeta oligomeric form.
Sarell CJ; Syme CD; Rigby SE; Viles JH
Biochemistry; 2009 May; 48(20):4388-402. PubMed ID: 19338344
[TBL] [Abstract][Full Text] [Related]
19. Periodate modification of human serum transferrin Fe(III)-binding sites. Inhibition of carbonate insertion into Fe(III)- and Cu(II)-chelator-transferrin ternary complexes.
Ross DC; Egan TJ; Purves LR
J Biol Chem; 1995 May; 270(21):12404-10. PubMed ID: 7759481
[TBL] [Abstract][Full Text] [Related]
20. Application of UV-irradiated Fe(III)-nitrilotriacetic acid (UV-Fe(III)NTA) and UV-NTA-Fenton systems to degrade model and natural occurring naphthenic acids.
Zhang Y; Chelme-Ayala P; Klamerth N; Gamal El-Din M
Chemosphere; 2017 Jul; 179():359-366. PubMed ID: 28388447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
